Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark F Berry

Showing results (61-70 of 225) with videos related to

Pageof 23
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|March 14, 2018
Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary?Douglas Z Liou, Leah M Backhus, Natalie S Lui, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 1, 2011
A model for morbidity after lung resection in octogenariansMark F Berry, Mark W Onaitis, Betty C Tong, et al.
Journal of Thoracic Disease|April 30, 2015
Adjuvant chemotherapy after resection of N1 non-small cell lung cancer: differential impact of new evidence on physician and patient decisionsBrooke K Coleman, Lesley H Curtis, Mark W Onaitis, et al.
Journal of the American College of Surgeons|October 23, 2012
Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008Mathias Worni, Jeremiah Martin, Beat Gloor, et al.
The Annals of Thoracic Surgery|June 3, 2004
Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac functionVasant Jayasankar, Lawrence T Bish, Timothy J Pirolli, et al.
Annals of Surgical Oncology|September 7, 2014
Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patientsMark F Berry, Brooke K Coleman, Lesley H Curtis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?Paul J Speicher, Lin Gu, Xiaofei Wang, et al.
The Annals of Thoracic Surgery|November 12, 2013
Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survivalMark F Berry, Mathias Worni, Xiaofei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Reply to D.A. PalmaChi-Fu Jeffrey Yang, Derek Y Chan, Thomas A D'Amico, et al.
Journal of Thrombosis and Thrombolysis|November 1, 2016
Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patientsNathan H Waldron, Torijaun Dallas, Loretta Erhunmwunsee, et al.
Pageof 23

Showing results (61-70 of 225) with videos related to

Sort By:
Pageof 23
The Journal of Thoracic and Cardiovascular Surgery|March 14, 2018
Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary?Douglas Z Liou, Leah M Backhus, Natalie S Lui, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 1, 2011
A model for morbidity after lung resection in octogenariansMark F Berry, Mark W Onaitis, Betty C Tong, et al.
Journal of Thoracic Disease|April 30, 2015
Adjuvant chemotherapy after resection of N1 non-small cell lung cancer: differential impact of new evidence on physician and patient decisionsBrooke K Coleman, Lesley H Curtis, Mark W Onaitis, et al.
Journal of the American College of Surgeons|October 23, 2012
Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008Mathias Worni, Jeremiah Martin, Beat Gloor, et al.
The Annals of Thoracic Surgery|June 3, 2004
Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac functionVasant Jayasankar, Lawrence T Bish, Timothy J Pirolli, et al.
Annals of Surgical Oncology|September 7, 2014
Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patientsMark F Berry, Brooke K Coleman, Lesley H Curtis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?Paul J Speicher, Lin Gu, Xiaofei Wang, et al.
The Annals of Thoracic Surgery|November 12, 2013
Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survivalMark F Berry, Mathias Worni, Xiaofei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Reply to D.A. PalmaChi-Fu Jeffrey Yang, Derek Y Chan, Thomas A D'Amico, et al.
Journal of Thrombosis and Thrombolysis|November 1, 2016
Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patientsNathan H Waldron, Torijaun Dallas, Loretta Erhunmwunsee, et al.
Pageof 23